Organon & Co. (BMV:OGN)

Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of MXN 32.57 billion. The enterprise value is 186.57 billion.

Market Cap	32.57B
Enterprise Value	186.57B

Important Dates

The last earnings date was Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	Aug 15, 2025

Share Statistics

Current Share Class	259.97M
Shares Outstanding	n/a
Shares Change (YoY)	+1.06%
Shares Change (QoQ)	-0.32%
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	82.75%
Float	258.73M

Valuation Ratios

The trailing PE ratio is 2.47 and the forward PE ratio is 1.77.

PE Ratio	2.47
Forward PE	1.77
PS Ratio	0.27
PB Ratio	2.36
P/TBV Ratio	n/a
P/FCF Ratio	2.62
P/OCF Ratio	2.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.78, with an EV/FCF ratio of 15.04.

EV / Earnings	14.13
EV / Sales	1.60
EV / EBITDA	5.78
EV / EBIT	7.40
EV / FCF	15.04

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 12.14.

Current Ratio	1.65
Quick Ratio	0.75
Debt / Equity	12.14
Debt / EBITDA	5.11
Debt / FCF	13.52
Interest Coverage	2.65

Financial Efficiency

Return on equity (ROE) is 159.64% and return on invested capital (ROIC) is 9.21%.

Return on Equity (ROE)	159.64%
Return on Assets (ROA)	6.62%
Return on Invested Capital (ROIC)	9.21%
Return on Capital Employed (ROCE)	12.69%
Revenue Per Employee	11.84M
Profits Per Employee	1.32M
Employee Count	10,000
Asset Turnover	0.49
Inventory Turnover	1.99

Taxes

Income Tax	-641.18M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-65.88%
50-Day Moving Average	224.93
200-Day Moving Average	464.65
Relative Strength Index (RSI)	31.62
Average Volume (20 Days)	2,254

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.42

Income Statement

In the last 12 months, Organon & Co. had revenue of MXN 118.45 billion and earned 13.20 billion in profits. Earnings per share was 50.69.

Revenue	118.45B
Gross Profit	67.00B
Operating Income	25.61B
Pretax Income	12.56B
Net Income	13.20B
EBITDA	31.63B
EBIT	25.61B
Earnings Per Share (EPS)	50.69

Balance Sheet

The company has 11.30 billion in cash and 167.76 billion in debt, giving a net cash position of -156.47 billion.

Cash & Cash Equivalents	11.30B
Total Debt	167.76B
Net Cash	-156.47B
Net Cash Per Share	n/a
Equity (Book Value)	13.82B
Book Value Per Share	53.17
Working Capital	34.36B

Cash Flow

In the last 12 months, operating cash flow was 15.58 billion and capital expenditures -3.17 billion, giving a free cash flow of 12.41 billion.

Operating Cash Flow	15.58B
Capital Expenditures	-3.17B
Free Cash Flow	12.41B
FCF Per Share	n/a

Margins

Gross margin is 56.57%, with operating and profit margins of 21.62% and 11.14%.

Gross Margin	56.57%
Operating Margin	21.62%
Pretax Margin	10.60%
Profit Margin	11.14%
EBITDA Margin	26.70%
EBIT Margin	21.62%
FCF Margin	10.48%

Dividends & Yields

This stock pays an annual dividend of 12.18, which amounts to a dividend yield of 10.41%.

Dividend Per Share	12.18
Dividend Yield	10.41%
Dividend Growth (YoY)	-37.97%
Years of Dividend Growth	1
Payout Ratio	32.71%
Buyback Yield	-1.06%
Shareholder Yield	9.35%
Earnings Yield	40.53%
FCF Yield	38.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.27
Piotroski F-Score	5